These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 33069869

  • 41. Codeine-induced hyperalgesia and allodynia: investigating the role of glial activation.
    Johnson JL, Rolan PE, Johnson ME, Bobrovskaya L, Williams DB, Johnson K, Tuke J, Hutchinson MR.
    Transl Psychiatry; 2014 Nov 11; 4(11):e482. PubMed ID: 25386959
    [Abstract] [Full Text] [Related]

  • 42. Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain - A comparison with morphine.
    Lesniak A, Bochynska-Czyz M, Sacharczuk M, Benhye S, Misicka A, Bujalska-Zadrozny M, Lipkowski AW.
    Eur J Pharm Sci; 2016 Jun 30; 89():39-49. PubMed ID: 27094782
    [Abstract] [Full Text] [Related]

  • 43. Morphine sensitivity of spinal neurons in the chronic constriction injury neuropathic rat pain model.
    Hirsch SJ, Dickenson AH.
    Neurosci Lett; 2014 Mar 06; 562():97-101. PubMed ID: 24128881
    [Abstract] [Full Text] [Related]

  • 44. A new tridecapeptide with an octaarginine vector has analgesic therapeutic potential and prevents morphine-induced tolerance.
    Kashkin VA, Shekunova EV, Titov MI, Eliseev II, Gureev MA, Porozov YB, Makarova MN, Makarov VG.
    Peptides; 2018 Jan 06; 99():61-69. PubMed ID: 29175519
    [Abstract] [Full Text] [Related]

  • 45. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia.
    Kwiatkowski K, Popiolek-Barczyk K, Piotrowska A, Rojewska E, Ciapała K, Makuch W, Mika J.
    Cytokine; 2019 Jul 06; 119():202-213. PubMed ID: 31003094
    [Abstract] [Full Text] [Related]

  • 46. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
    Kwiatkowski K, Pawlik K, Ciapała K, Piotrowska A, Makuch W, Mika J.
    Front Immunol; 2020 Jul 06; 11():615327. PubMed ID: 33408720
    [Abstract] [Full Text] [Related]

  • 47. CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain.
    Bogacka J, Popiolek-Barczyk K, Pawlik K, Ciechanowska A, Makuch W, Rojewska E, Dobrogowski J, Przeklasa-Muszynska A, Mika J.
    Eur J Pharmacol; 2020 Aug 05; 880():173166. PubMed ID: 32407723
    [Abstract] [Full Text] [Related]

  • 48. Epigenetic regulation of spinal cord gene expression contributes to enhanced postoperative pain and analgesic tolerance subsequent to continuous opioid exposure.
    Sahbaie P, Liang DY, Shi XY, Sun Y, Clark JD.
    Mol Pain; 2016 Aug 05; 12():. PubMed ID: 27094549
    [Abstract] [Full Text] [Related]

  • 49. Endocannabinoid activation of CB1 receptors contributes to long-lasting reversal of neuropathic pain by repetitive spinal cord stimulation.
    Sun L, Tai L, Qiu Q, Mitchell R, Fleetwood-Walker S, Joosten EA, Cheung CW.
    Eur J Pain; 2017 May 05; 21(5):804-814. PubMed ID: 28107590
    [Abstract] [Full Text] [Related]

  • 50. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
    Abul-Husn NS, Sutak M, Milne B, Jhamandas K.
    Br J Pharmacol; 2007 Jul 05; 151(6):877-87. PubMed ID: 17502848
    [Abstract] [Full Text] [Related]

  • 51. Alternative pain management via endocannabinoids in the time of the opioid epidemic: Peripheral neuromodulation and pharmacological interventions.
    Lee MT, Mackie K, Chiou LC.
    Br J Pharmacol; 2023 Apr 05; 180(7):894-909. PubMed ID: 34877650
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
    Kwiatkowski K, Piotrowska A, Rojewska E, Makuch W, Jurga A, Slusarczyk J, Trojan E, Basta-Kaim A, Mika J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan 04; 64():68-78. PubMed ID: 26190414
    [Abstract] [Full Text] [Related]

  • 55. Stronger antinociceptive efficacy of opioids at the injured nerve trunk than at its peripheral terminals in neuropathic pain.
    Labuz D, Machelska H.
    J Pharmacol Exp Ther; 2013 Sep 04; 346(3):535-44. PubMed ID: 23820126
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice.
    Crowe MS, Wilson CD, Leishman E, Prather PL, Bradshaw HB, Banks ML, Kinsey SG.
    Br J Pharmacol; 2017 Dec 04; 174(23):4523-4539. PubMed ID: 28963716
    [Abstract] [Full Text] [Related]

  • 58. Lack of cross-tolerance between the antinociceptive effects of systemic morphine and asimadoline, a peripherally-selective kappa-opioid agonist, in CCI-neuropathic rats.
    Walker J, Catheline G, Guilbaud G, Kayser V.
    Pain; 1999 Dec 04; 83(3):509-516. PubMed ID: 10568859
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.